2ND MALIGNANCIES - RISK REDUCTION

被引：6

作者：

PETRU, E

SCHMAHL, D

机构：

来源：

CANCER TREATMENT REVIEWS | 1987年 / 14卷 / 3-4期

关键词：

D O I：

10.1016/0305-7372(87)90027-2

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：337 / 343

页数：7

共 8 条

[1] NONCARCINOGENIC CHEMOTHERAPY WITH A COMBINATION OF VINCRISTINE, METHOTREXATE AND 5-FLUOROURACIL (VMF) IN RATS [J].

BERGER, M ;

HABS, M ;

SCHMAHL, D .

INTERNATIONAL JOURNAL OF CANCER, 1983, 32 (02) :231-236

[2] COMBINATION CHEMOTHERAPY AS AN ADJUVANT TREATMENT IN OPERABLE BREAST-CANCER [J].

BONADONNA, G ;

BRUSAMOLINO, E ;

VALAGUSSA, P ;

ROSSI, A ;

BRUGNATELLI, L ;

BRAMBILLA, C ;

DELENA, M ;

TANCINI, G ;

BAJETTA, E ;

MUSUMECI, R ;

VERONESI, U .

NEW ENGLAND JOURNAL OF MEDICINE, 1976, 294 (08) :405-410

[3]

BROCK N, 1982, THERAPIEWOCHE, V32, P4975

[4] CARCINOGENIC ACTIVITY IN RATS OF COMBINED TREATMENT WITH CYCLOPHOSPHAMIDE, METHOTREXATE AND 5-FLUOROURACIL [J].

HABS, M ;

SCHMAHL, D ;

LIN, PZ .

INTERNATIONAL JOURNAL OF CANCER, 1981, 28 (01) :91-96

[5]

HABS MR, 1983, CANCER, V51, P606, DOI 10.1002/1097-0142(19830215)51:4<606::AID-CNCR2820510409>3.0.CO

[6]

2-S

[7] OCCURRENCE OF 2ND TUMORS IN MAN AFTER ANTI-CANCER DRUG-TREATMENT [J].

SCHMAHL, D ;

HABS, M ;

LORENZ, M ;

WAGNER, I .

CANCER TREATMENT REVIEWS, 1982, 9 (03) :167-194

[8] 2ND TUMORS AFTER CYTOSTATIC TREATMENT WITH ALKYLATING-AGENTS - TOXICOLOGICAL ASPECTS [J].

SCHMAHL, D ;

PETRU, E .

DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1986, 111 (21) :833-835

← 1 →